Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-25-009710
Filing Date
2025-03-10
Accepted
2025-03-10 16:30:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 23686
2 ex99.htm EX-99 47393
  Complete submission text file 0001493152-25-009710.txt   73131
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Subject) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-83932 | Film No.: 25724169
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 15 QUEENS ROAD CENTRAL, UNIT 3002-3004 30TH FLOOR, GLOUCESTER TWR, THE LANDMARK HONG KONG F4 0000000000
Business Address 15 QUEENS ROAD CENTRAL, UNIT 3002-3004 30TH FLOOR, GLOUCESTER TWR, THE LANDMARK HONG KONG F4 0000000000 852 31219699
ABG Management Ltd. (Filed by) CIK: 0001832106 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G